MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$2.79
0.16 (6.08%)
▲
5d:
+3.33%
30d:
+22.37%
90d:
-50.09%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 14, 2026
14d
Smart Money Accumulation
MNKD is down 9.9% this week, but smart money is accumulating calls. Top strike: $3 2026-05-29 with 455 OI. Call ratio: 100% View Scanner →
Strength: 9.9/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 19.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 19.2% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $2.79, which is considered extended relative to its 30-day fair value range of $2.41 to $2.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.4) compared to its historical average (27.4). Remarkably, the market is currently pricing in an annual earnings decline of 19.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a strong downtrend. Immediate support is located at $2.59, while resistance sits at $2.98. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: MNKD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.81 (+144.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MNKD is in a strong downtrend. Immediate support is located at $2.59, while resistance sits at $2.98. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: MNKD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.81 (+144.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.41 -
$2.76
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Trading 144.2% below Wall St target ($6.81)
Trading Range Analysis
30-Day Trading Range
$2.41 -
$2.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.59
Resistance Level
$2.98
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.43
Wall Street Target
$6.81
(+144.2%)
Revenue Growth (YoY)
45.8%
Earnings Growth (YoY)
-34.9%
Profit Margin
1.7%
Valuation Discount vs History
-19.2% cheaper
PE vs Historical
14.4 vs 27.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.2%
(market-implied from PE analysis)
1-Year Target
$2.51
(-10%)
2-Year Target
$2.26
(-19%)
3-Year Target
$2.03
(-27%)
3-Yr Target (if PE normalizes)
(PE: 14→27)
$3.86
(+38%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 123.0%)
$13.45
(+382%)
Base:
(SPY PE: 14.4, Growth: 123.0%)
$9.42
(+238%)
Bear:
(PE: 12.3, Growth: 123.0%)
$8.00
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.4 to 27.4
Stabilization Target:
$5.30
(+89.8%)
PE Expansion Potential:
+89.8%
Share & Embed Analysis
Last updated: April 29, 2026 8:46 AM ET
Data refreshes hourly during market hours. Next update: 9:46 AM
Data refreshes hourly during market hours. Next update: 9:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Stuart A Tross
SELL
47006 shares
2026-01-08
Michael Castagna
SELL
65804 shares
2025-12-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 53 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
